Montelukast as monotherapy in children with mild persistent asthma

Wei Fong Wu, Jiunn Ren Wu, Zen Kong Dai, Chin Wen Tsai, Tzu Chun Tsai, Chia Chun Chen, Chueh Yuan Yang

研究成果: 雜誌貢獻文章

4 引文 (Scopus)

摘要

The cysteinyl leukotrienes cause bronchoconstriction, increased mucus production and airway inflammation, three major features of asthma. Several randomized controlled trials have shown the efficacy of leukotriene receptor antagonists for improving asthma outcomes. The drug is favored for treating childhood asthma, where poor compliance with inhalation therapy is a therapeutic challenge. To assess the effectiveness of Montelukast in asthmatic children under real-life conditions, a prospective, single-arm, multicenter, open-label observational study was performed on asthmatic children 2 to 14 years old with a history of physician-diagnosed mild persistent asthma. Montelukast was given once daily for 12 consecutive weeks. By the end a significant improvement of the daytime asthma symptom score, nighttime asthma score, peak expiratory flow rate (PEFR) and mean score of the investigators' global evaluation was noted (p < 0.05). These results suggest that montelukast is an effective monotherapy controller in children with mild persistent asthma.

原文英語
頁(從 - 到)173-180
頁數8
期刊Asian Pacific Journal of Allergy and Immunology
27
發行號4
出版狀態已發佈 - 十二月 1 2009
對外發佈Yes

指紋

montelukast
Asthma
Leukotriene Antagonists
Respiratory Therapy
Peak Expiratory Flow Rate
Bronchoconstriction
Mucus
Observational Studies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

引用此文

Montelukast as monotherapy in children with mild persistent asthma. / Wu, Wei Fong; Wu, Jiunn Ren; Dai, Zen Kong; Tsai, Chin Wen; Tsai, Tzu Chun; Chen, Chia Chun; Yang, Chueh Yuan.

於: Asian Pacific Journal of Allergy and Immunology, 卷 27, 編號 4, 01.12.2009, p. 173-180.

研究成果: 雜誌貢獻文章

Wu, Wei Fong ; Wu, Jiunn Ren ; Dai, Zen Kong ; Tsai, Chin Wen ; Tsai, Tzu Chun ; Chen, Chia Chun ; Yang, Chueh Yuan. / Montelukast as monotherapy in children with mild persistent asthma. 於: Asian Pacific Journal of Allergy and Immunology. 2009 ; 卷 27, 編號 4. 頁 173-180.
@article{9c20d9b6855f482d84171a438e1bebd4,
title = "Montelukast as monotherapy in children with mild persistent asthma",
abstract = "The cysteinyl leukotrienes cause bronchoconstriction, increased mucus production and airway inflammation, three major features of asthma. Several randomized controlled trials have shown the efficacy of leukotriene receptor antagonists for improving asthma outcomes. The drug is favored for treating childhood asthma, where poor compliance with inhalation therapy is a therapeutic challenge. To assess the effectiveness of Montelukast in asthmatic children under real-life conditions, a prospective, single-arm, multicenter, open-label observational study was performed on asthmatic children 2 to 14 years old with a history of physician-diagnosed mild persistent asthma. Montelukast was given once daily for 12 consecutive weeks. By the end a significant improvement of the daytime asthma symptom score, nighttime asthma score, peak expiratory flow rate (PEFR) and mean score of the investigators' global evaluation was noted (p < 0.05). These results suggest that montelukast is an effective monotherapy controller in children with mild persistent asthma.",
author = "Wu, {Wei Fong} and Wu, {Jiunn Ren} and Dai, {Zen Kong} and Tsai, {Chin Wen} and Tsai, {Tzu Chun} and Chen, {Chia Chun} and Yang, {Chueh Yuan}",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "27",
pages = "173--180",
journal = "Asian Pacific Journal of Allergy and Immunology",
issn = "0125-877X",
publisher = "The Allergy and Immunology Society of Thailand",
number = "4",

}

TY - JOUR

T1 - Montelukast as monotherapy in children with mild persistent asthma

AU - Wu, Wei Fong

AU - Wu, Jiunn Ren

AU - Dai, Zen Kong

AU - Tsai, Chin Wen

AU - Tsai, Tzu Chun

AU - Chen, Chia Chun

AU - Yang, Chueh Yuan

PY - 2009/12/1

Y1 - 2009/12/1

N2 - The cysteinyl leukotrienes cause bronchoconstriction, increased mucus production and airway inflammation, three major features of asthma. Several randomized controlled trials have shown the efficacy of leukotriene receptor antagonists for improving asthma outcomes. The drug is favored for treating childhood asthma, where poor compliance with inhalation therapy is a therapeutic challenge. To assess the effectiveness of Montelukast in asthmatic children under real-life conditions, a prospective, single-arm, multicenter, open-label observational study was performed on asthmatic children 2 to 14 years old with a history of physician-diagnosed mild persistent asthma. Montelukast was given once daily for 12 consecutive weeks. By the end a significant improvement of the daytime asthma symptom score, nighttime asthma score, peak expiratory flow rate (PEFR) and mean score of the investigators' global evaluation was noted (p < 0.05). These results suggest that montelukast is an effective monotherapy controller in children with mild persistent asthma.

AB - The cysteinyl leukotrienes cause bronchoconstriction, increased mucus production and airway inflammation, three major features of asthma. Several randomized controlled trials have shown the efficacy of leukotriene receptor antagonists for improving asthma outcomes. The drug is favored for treating childhood asthma, where poor compliance with inhalation therapy is a therapeutic challenge. To assess the effectiveness of Montelukast in asthmatic children under real-life conditions, a prospective, single-arm, multicenter, open-label observational study was performed on asthmatic children 2 to 14 years old with a history of physician-diagnosed mild persistent asthma. Montelukast was given once daily for 12 consecutive weeks. By the end a significant improvement of the daytime asthma symptom score, nighttime asthma score, peak expiratory flow rate (PEFR) and mean score of the investigators' global evaluation was noted (p < 0.05). These results suggest that montelukast is an effective monotherapy controller in children with mild persistent asthma.

UR - http://www.scopus.com/inward/record.url?scp=77953634688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953634688&partnerID=8YFLogxK

M3 - Article

C2 - 20232571

AN - SCOPUS:77953634688

VL - 27

SP - 173

EP - 180

JO - Asian Pacific Journal of Allergy and Immunology

JF - Asian Pacific Journal of Allergy and Immunology

SN - 0125-877X

IS - 4

ER -